HealthEquity Stock Price, News & Analysis (NASDAQ:HQY)

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" HQY shares.
View HQY analyst ratings or view top-rated stocks.

7 Wall Street analysts have issued 1 year price targets for HealthEquity's shares. Their HQY share price targets range from $72.00 to $94.00. On average, they expect the company's stock price to reach $84.14 in the next year. This suggests a possible upside of 25.9% from the stock's current price.
View analysts price targets for HQY or view top-rated stocks among Wall Street analysts.

HealthEquity's stock was trading at $61.64 at the beginning of the year. Since then, HQY stock has increased by 8.5% and is now trading at $66.85.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, December 5th 2023.
View our HQY earnings forecast.

HealthEquity will be holding an earnings conference call on Tuesday, December 5th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

HealthEquity, Inc. (NASDAQ:HQY) issued its quarterly earnings results on Tuesday, September, 5th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.06. The firm had revenue of $243.55 million for the quarter, compared to analyst estimates of $238.89 million. HealthEquity had a net margin of 1.37% and a trailing twelve-month return on equity of 5.08%.

ETFs with the largest weight of HealthEquity (NASDAQ:HQY) stock in their portfolio include Motley Fool Mid-Cap Growth ETF (TMFM), SPDR S&P Health Care Services ETF (XHS), Global X FinTech Thematic ETF (FINX), Motley Fool Small-Cap Growth ETF (TMFS), MFAM Small-Cap Growth ETF (MFMS), Nuveen Small Cap Select ETF (NSCS), Putnam Sustainable Future ETF (PFUT) and iShares U.S. Healthcare Providers ETF (IHF).

HealthEquity updated its FY24 earnings guidance on Tuesday, September, 5th. The company provided earnings per share guidance of $1.97-$2.06 for the period, compared to the consensus EPS estimate of $1.93. The company issued revenue guidance of $980-$990 million, compared to the consensus revenue estimate of $981.09 million.

359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

HealthEquity's stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (6.60%), William Blair Investment Management LLC (3.09%), JPMorgan Chase & Co. (2.72%), Clearbridge Investments LLC (2.58%), Brown Advisory Inc. (2.42%) and Allspring Global Investments Holdings LLC (1.57%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Elimelech Rosner, Frank Corvino, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker, Tyson D Murdock and William Robert Otten.
View institutional ownership trends.

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.